- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pulmonary Fibrosis in Australia
Total 694 results
-
siRNAgen Therapeutics Inc.Active, not recruiting
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisAustralia
-
The Prince Charles HospitalMater Medical Research InstituteCompletedIdiopathic Pulmonary FibrosisAustralia
-
Monash UniversityRecruitingFibrotic Interstitial Lung DiseaseAustralia
-
Syndax PharmaceuticalsDevPro BiopharmaRecruitingIdiopathic Pulmonary FibrosisAustralia
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
Pulmongene Ltd.CompletedIdiopathic Pulmonary FibrosisAustralia
-
Zai Lab Pty. Ltd.UnknownChronic Obstructive Pulmonary Disease | Asthma | Idiopathic Pulmonary FibrosisAustralia
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Dr. Christopher LambersClinical Trials Coordination Centre, Medical University of ViennaWithdrawnIdiopathic Pulmonary Fibrosis | Lung Transplant; ComplicationsAustria
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingPulmonary Fibrosis | TumorAustralia
-
Novartis PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisUnited States, Australia, Germany, Czechia, Argentina, Poland, Netherlands
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary
-
Neovii BiotechCompletedBronchiectasis | Idiopathic Pulmonary Fibrosis | Cystic Fibrosis | Chronic Obstructive Pulmonary | Pulmonary Vascular DiseaseUnited States, Australia, Austria, Canada
-
Medical University of ViennaCompleted
-
Gilead SciencesTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary HypertensionUnited States, Germany, United Kingdom, Australia, Canada, Italy, Austria
-
Galecto Biotech ABSyneos Health; bioRASI, LLCCompletedIdiopathic Pulmonary Fibrosis (IPF)United States, Spain, Israel, France, United Kingdom, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Bayside HealthUniversity of MelbourneCompletedCystic Fibrosis | Chronic Obstructive Pulmonary Disease (COPD)Australia
-
CelgeneCompletedPulmonary FibrosisUnited States, Australia
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
CSL BehringCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, United Kingdom, Australia, Germany, Poland, Belgium, Austria, Denmark, Italy, Spain
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
Bridge Biotherapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of, Australia, Israel, Poland
-
University of SydneyMonash University; University of Tasmania; Lung Foundation AustraliaNot yet recruitingPulmonary Fibrosis | Lung Diseases, InterstitialAustralia
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisCanada, Malaysia, Australia, Mexico, Korea, Republic of
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Canada, Belgium, Australia, United Kingdom, Germany, Italy, France, Japan, Mexico, India
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisBelgium, France, Germany, Israel, Spain, United States, Switzerland, Colombia, Mexico, Italy, Czech Republic, Australia, Canada, Austria, Poland, United Kingdom, Argentina, Netherlands, Peru, Ireland, Brazil, Chile
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Korea, Republic of, Australia, Italy, United Kingdom, Germany, China, Finland, Denmark, Netherlands, Greece, Argentina, Austria, Chile, Czechia, Hungary, Japan, Poland, Russian Federation, Ukraine
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, Korea, Republic of, Belgium, Czechia, Australia, Germany, United Kingdom, United States, France, Finland, Japan, Poland, Hungary
-
BiogenTerminatedIdiopathic Pulmonary FibrosisUnited States, Italy, Belgium, Czechia, Russian Federation, Korea, Republic of, Australia, France, Israel, Spain, Poland, Netherlands, Denmark, Greece, Argentina, Chile, United Kingdom
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
MedImmune LLCTerminatedIdiopathic Pulmonary FibrosisUnited States, Australia, Korea, Republic of, Peru, Canada, Israel
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
Trevi TherapeuticsRecruitingIdiopathic Pulmonary FibrosisUnited Kingdom, Australia, Netherlands, Italy, Spain, Poland, Turkey, Canada, Chile, Germany
-
Indiana University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCystic FibrosisUnited States, Australia
-
Pliant Therapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Australia, Taiwan, Korea, Republic of, Portugal, Germany, Israel, Denmark, New Zealand, Netherlands, Canada, Chile, Czechia, France, Greece, Italy, Poland
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
-
Redx Pharma PlcSimbec ResearchRecruitingFibrosis | IPFItaly, Spain, United States, Belgium, United Kingdom, Austria, Czechia, Poland, Switzerland
-
SanofiCompletedIdiopathic Pulmonary FibrosisCzechia, Korea, Republic of, Mexico, Israel, Spain, Greece, Chile, Canada, Colombia, Turkey, Denmark, France, United States, Argentina, Australia, Germany, Italy, Portugal, United Kingdom
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited Kingdom, Belgium, Germany, France, Sweden, Austria, Denmark, Italy
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Japan, Belgium, Taiwan, Denmark, Germany, United Kingdom, Greece, Australia, Czechia, Brazil, Chile, Peru, Turkey
-
AmgenActive, not recruitingIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Australia, Japan, Canada, Taiwan, Netherlands, Italy, Chile, Greece, Mexico, Germany, France, Argentina, Poland, Turkey, South Africa, United Kingdom
-
United TherapeuticsRecruitingIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseTaiwan, Belgium, Spain, Korea, Republic of, Germany, Australia, Chile, Denmark, France, Mexico, Israel, Italy, Netherlands, Argentina, New Zealand, Peru